OSAM
MIRM icon

O'Shaughnessy Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

O'Shaughnessy Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$921K Buy
+7,864
New +$790K ﹤0.01% 1294
2025
Q4 		– Sell
-2,855
Closed -$209K – 2709
2025
Q3 		$209K Buy
+2,855
New +$181K ﹤0.01% 1942

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

O'Shaughnessy Asset Management's MIRM Position: Q2 2026 in Review

O'Shaughnessy Asset Management opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 7,864 shares worth $921K. The stake represents ﹤0.01% of the portfolio and ranks #1294 among its holdings. This is a return to the name: O'Shaughnessy Asset Management previously reported a position in MIRM as recently as Q3 2025.

O'Shaughnessy Asset Management first reported a position in MIRM in Q3 2025 and has held it in 2 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • O'Shaughnessy Asset Management held 7,864 shares of Mirum Pharmaceuticals worth $921K as of Q2 2026.
  • Mirum Pharmaceuticals was a new O'Shaughnessy Asset Management position in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #1294 holding.
  • O'Shaughnessy Asset Management first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.